Pegylated G-CSF is named as an intervention in 2 current clinical trials in our Ireland, UK and USA registers. None are recruiting at the moment. All registered phases are Phase 3. The sponsor with the most trials is Alliance for Clinical Trials in Oncology (1). The most-studied condition is Germ Cell Tumor.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC
NCT01933932 · ClinicalTrials.gov ↗ · Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
|
Phase 3 | Active, closed | AstraZeneca | UK, USA |
|
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors
NCT02375204 · ClinicalTrials.gov ↗ · Germ Cell Tumor, Teratoma, Choriocarcinoma
|
Phase 3 | Active, closed | Alliance for Clinical Trials in Oncology | Ireland |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Lead sponsor | Trials |
|---|---|
| Alliance for Clinical Trials in Oncology | 1 |
| AstraZeneca | 1 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Ireland | 1 | 0 |
| Clinical trials in UK | 1 | 0 |
| Clinical trials in USA | 1 | 0 |
A trial with sites in more than one country appears in each of those registers.
2 current trials in our Ireland, UK and USA registers name Pegylated G-CSF as a drug or biological intervention, as of the registry sync on 25 September 2026. Completed and withdrawn studies are not counted.
Not at the moment. None of the 2 trials in our registers is recruiting; they are active but closed to enrolment, not yet open, or enrolling by invitation. Only the study team can confirm whether a patient is eligible.
Alliance for Clinical Trials in Oncology (1) and AstraZeneca (1). The number in brackets is how many trials each organisation leads.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Pegylated G-CSF works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Pegylated G-CSF works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Pegylated G-CSF (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 25 Sep 2026.